Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

503 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

NCT06508931

Conditions
B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Hôpital Robert Debré Paris, Boulevard Sérurier 48, France
  • Institut Gustave Roussy Villejuif, France
  • Universitaetsklinikum Muenster (UKM) - Klinik fuer Kinder- und Jugendmedizin - Paediatrische Haematologie und Onkologie Münster, Albert-Schweitzer-Campus 1, Gebaeude A1, Germany
  • IRCCS Ospedale Pediatrico Bambino Gesù Rome, Piazza Sant Onofrio 4, Italy
View Trial Details
Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

NCT06378190

Conditions
B-cell Lymphoma Recurrent, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital Clínic Barcelona, Spain
  • Institut Català d'Oncologia Hospital L'Hospitalet de Llobregat, Barcelona, Spain
  • Fundación Jiménez Díaz Hospital Madrid, Spain
  • Virgen de la Arrixaca University Hospital El Palmar, Mur, Spain
View Trial Details
Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

NCT04329728

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UCLA Medical Center of Hematology/Oncology Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details

Related conditions